Results 201 to 210 of about 8,177,958 (249)
Some of the next articles are maybe not open access.

HHV-6 and the Integument

2006
Publisher Summary A prospective population-based study was recently undertaken to determine the clinical features of primary human herpesvirus-6 (HHV-6) infection outside the acute-care setting. Several clinical conditions such as skin rash resembling acute graft-versus-host-disease (GVHD), bone marrow suppression, interstitial pneumonitis, and ...
openaire   +2 more sources

HHV-6 and the Respiratory System

2006
Publisher Summary Various inflammatory reactions occur in the respiratory tract, both in primary and in non-primary infections with human herpesvirus-6 (HHV-6). Pneumonia following primary HHV-6 infection is rare, yet when occurring, it will usually require hospital admission of the seriously ill child. It occurs during the initial phase of infection,
Wiersbitzky H   +2 more
openaire   +2 more sources

Proteins of HHV-6

2006
Publisher Summary Human herpesvirus-6 (HHV-6) is classified into variants A (HHV-6A) and B (HHV-6B) on the basis of distinct genetic, immunological, and biological characteristics. The HHV-6 genome contains open reading frames (ORFs) U1-U100 and flanking 8–9 kb terminal direct repeats (DRs) at either end.
openaire   +2 more sources

HHV-6, 7 and their related diseases

Journal of Dermatological Science, 2000
Human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) are relatively recently discovered beta-herpesvirus. They are prevalent in the human population. Primary infection of HHV-6 has been associated with exanthem subitum and febrile illness. Little information is known about the clinical characteristics of primary infection with HHV-7, although ...
openaire   +3 more sources

HHV-6 in Cardiovascular Pathology

2006
Publisher Summary Among major clinical symptoms described for active human herpesvirus-6 (HHV-6) infection were palpitations, tachycardia, and arrhythmia as well as not-further specified ‘‘myocarditis'’. The cardiovascular system (CVS) may be a possible target for HHV-6 infections.
L. Maximilian Buja, L. Maximilian Buja
openaire   +2 more sources

Strain Variants of HHV-6

2006
Publisher Summary This chapter describes various aspects of human herpesvirus-6 (HHV-6) variants. The HHV-6A and B variants are two distinct viruses and should be reclassified according to the nomenclature of herpesviruses. A nomenclature of HHV-6 strain groups was based on tropism on CD4+ T-lymphocytes, but each group was characterized by strain, GS
openaire   +2 more sources

HHV-6 inhibition by two polar compounds

Antiviral Research, 1992
Dimethyl sulphoxide and dimethyl formamide, two polar compounds and powerful cell differentiation inducers, inhibit HHV-6 infection when added to HHV-6-infected HSB2 cultures. This was established by a delay in the time-course of infection and in the development of virus-induced cytopathic effects.
Viza D   +3 more
openaire   +2 more sources

Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV‐6 in post‐infective fatigue syndrome

Journal of Medical Virology, 2010
Multiple previous studies have sought evidence for ongoing, active infection with, or reactivation of, Herpesviruses in patients with chronic fatigue syndrome (CFS), with conflicting results.
B. Cameron   +7 more
semanticscholar   +1 more source

Current understanding of human herpesvirus 6 (HHV-6) chromosomal integration.

Antiviral Research, 2020
Giulia Aimola   +3 more
semanticscholar   +1 more source

Therapeutic Approaches to HHV-6 Infection

2006
Publisher Summary In the absence of human herpesvirus-6 (HHV-6)-specific therapies, treatment of HHV-6 infections relies on the relatively broad-spectrum antiherpetic agents (val)ganciclovir and foscarnet. In case of ganciclovir, the anti-HHV-6 activity is diminished by two factors: inefficient phosphorylation of ganciclovir by the HHV-6 pU69 protein
Erik De Clercq   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy